Thousand Oaks, CA, United States of America

Chen Zhou


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Inventor Chen Zhou

Introduction

Chen Zhou is a notable inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of methods for identifying functional antibodies. His work has implications for various applications in medical research and therapeutic development.

Latest Patents

Chen Zhou holds a patent for "Methods for identifying functional antibodies." This invention provides methods for screening multimeric antibodies produced by mammalian cells to find those that exhibit a biological function. The methods can be used to screen large numbers of antibodies, which may be cell surface, secreted, or intracellular antibodies. Antibodies can be screened to find those that bind antigen more avidly or those that compete with a ligand that binds to the antigen for binding. Any biological function that can be tested in vitro can be used to screen the antibodies. Nucleic acids encoding the antibodies that exhibit the biological function can be obtained in a number of ways.

Career Highlights

Chen Zhou is currently employed at Amgen Inc., a leading biotechnology company. His work at Amgen focuses on advancing the understanding and application of antibodies in therapeutic contexts. With a patent portfolio that includes innovative methods, he has established himself as a key contributor in his field.

Collaborations

Chen Zhou has collaborated with notable colleagues such as Wenyan Shen and Francis Hall Martin. These collaborations have further enhanced the research and development efforts within his team.

Conclusion

In summary, Chen Zhou is an accomplished inventor whose work on functional antibodies has the potential to impact medical research significantly. His contributions at Amgen Inc. and his innovative patent reflect his dedication to advancing biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…